参考文献/References:
[1] THILAK S,BROWN P,WHITEHOUSE T,et al.Diagnosis and management of subarachnoid haemorrhage[J].Nat Commun,2024,15(1):1850.
[2] 王静予,孔令军,费智敏,等.术后脑脊液乳酸水平和乳酸清除率对动脉瘤性蛛网膜下腔出血预后的预测价值[J].中国实用神经疾病杂志,2021,24(14):1203-1209.
[3] WAN X,WU X,KANG J,et al.Prognostic model for aneurysmal subarachnoid hemorrhage patients requiring mechanical ventilation[J].Ann Clin Transl Neurol,2023,10(9):1569-1577.
[4] 李泽新,张贝贝.血清缺氧诱导因子-1α、前列腺素E2水平与动脉瘤性蛛网膜下腔出血关系及对脑血管痉挛的预测价值[J].陕西医学杂志,2023,52(2):141-144,191.
[5] 李栋,赵志远,翟延青,等.血管介入栓塞术治疗动脉瘤性蛛网膜下腔出血的疗效及对患者血管内皮功能的影响[J].山东医药,2023,63(4):53-55.
[6] FITZGERALD M,TAN T,ROSENFELD J V,et al.An initial Glasgow Coma Scale score of 8 or less does not define severe brain injury[J].Emerg Med Australas,2022,34(3):459-461.
[7] 郑鉴峰,郭宗铎,孙晓川.小型颅内动脉瘤破裂发生大量蛛网膜下腔出血及再出血的危险因素分析[J].中国脑血管病杂志,2024,21(6):361-368.
[8] LI L,BAN C,RUAN H,et al.Prognostic value of albumin to fibrinogen ratio for mortality in patients with hypertrophic cardiomyopathy[J].BMC Cardiovasc Disord,2023,23(1):559.
[9] ZHANG Y,MAN L.Albumin-to-fibrinogen ratio is an independent predictor of corticosteroid response and prognosis in patients with IgA nephropathy[J].Eur J Med Res,2023,28(1):146.
[10] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组,中华医学会神经病学分会神经血管介入协作组.中国蛛网膜下腔出血诊治指南2019[J].中华神经科杂志,2019,52(12):1006-1021.
[11] BODIEN Y G,BARRA A,TEMKIN N R,et al.Diagnosing level of consciousness:The limits of the Glasgow Coma Scale total score[J].J Neurotrauma,2021,38(23):3295-3305.
[12] SAVER J L,CHAISINANUNKUL N,CAMPBELL B C V,et al.Standardized nomenclature for modified rankin scale global disability outcomes:Consensus recommendations from stroke therapy academic industry roundtable Ⅺ[J].Stroke,2021,52(9):3054-3062.
[13] 桂先正,向仲勋,罗建利,等.SAH患者动脉瘤夹闭术后脑水肿发生情况及Logistic分析[J].中国实用神经疾病杂志,2023,26(8):968-973.
[14] 牛冰,席从林,陈伟.动脉瘤性蛛网膜下腔出血患者发生疲乏的影响因素及其风险预测列线图模型构建[J].实用心脑肺血管病杂志,2023,31(10):60-64.
[15] D'AMATO S A,CHANG T R.Advances in intracranial hemorrhage:Subarachnoid hemorrhage and intracerebral hemorrhage[J].Crit Care Clin,2023,39(1):71-85.
[16] CHEN H Y,ELMER J,ZAFAR S F,et al.Combining transcranial doppler and EEG data to predict delayed cerebral ischemia after subarachnoid hemorrhage[J].Neurology,2022,98(5):e459-e469.
[17] SHAH V A,GONZALEZ L F,SUAREZ J I.Therapies for delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage[J].Neurocrit Care,2023,39(1):36-50.
[18] DE-JONG G,AQUARIUS R,SANAAN B,et al.Prediction models in aneurysmal subarachnoid hemorrhage:Forecasting clinical outcome with artificial intelligence[J].Neurosurgery,2021,88(5):e427-e434.
[19] 范丹洁,韩斌,冯善刚,等.动脉瘤性蛛网膜下腔出血患者短期生存预后的影响因素分析[J].中华神经外科杂志,2024,40(5):500-504.
[20] 马建宁,徐占义,张洪鑫.aSAH患者术后发生延迟性脑缺血的影响因素及风险预警模型构建[J].中国实用神经疾病杂志,2024,27(4):453-457.
[21] 杨满平,庹小双,刘晓钰,等.血管内治疗颅内动脉瘤患者的预后影响因素分析[J].空军军医大学学报,2023,44(4):334-339.
[22] ANDUALEM H,BEYENE T,TULI W.Knowledge and practice about Glasgow Coma Scale assessment among nurses working in adult intensive care units of federal public hospitals in Addis Ababa,Ethiopia:A cross-sectional study[J].Ethiop J Health Sci,2022,32(5):895-904.
[23] 孙书光,麻来峰,仝朋飞.早期显微外科手术治疗高分级动脉瘤性蛛网膜下腔出血患者短期预后的影响因素[J].中国实用神经疾病杂志,2024,27(6):706-710.
[24] AMARO E,MOORE-LOTRIDGE S N,WESSINGER B,et al.Albumin and the fibrinogen-to-albumin ratio:Biomarkers for the acute phase response following total knee arthroplasty[J].PLoS One,2021,16(2):e0247070.
[25] WANG H R,MA J,GUO Y Z,et al.Combination of albumin/fibrinogen ratio and admission Hunt-Hess Scale score as an independent predictor of clinical outcome in aneurysmal subarachnoid hemorrhage[J].World Neurosurg,2024,181:e322-e329.